Abstract
Background: In 2020 an estimated 184,615 new cases of laryngeal cancer were diagnosed worldwide1. Current evidence suggests no difference between endoscopic laser surgery (ELS) and radiotherapy (RT) with regards to oncological outcomes of early laryngeal cancer2. Patient management may therefore be directed towards voice and quality of life (QOL) outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
